Neoplasms, Ovarian Recruiting Phase 1 Trials for Oregovomab (DB04964)

Also known as: Ovarian neoplasm / Ovarian Neoplasms / Neoplasms,Ovarian / Ovarian neoplasia / Ovarian tumor / Ovarian neoplasm NOS

IndicationStatusPhase
DBCOND0030336 (Neoplasms, Ovarian)Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03162562The Safety and Antitumor Activity of the Combination of Oregovomab and Hiltonol in Recurrent Advanced Ovarian CancerTreatment